Clinical studies have shown that women with higher soy intake, which correlates with higher genistein levels, have a reduced risk of developing breast cancer Moreover, clinical trials have shown that genistein can reduce prostate-specific antigen (PSA) levels in patients with prostate cancer, suggesting a potential therapeutic role. This evidence concerns the gene KLK3 and breast carcinoma.